Processing 00000000.tx.1: In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters Frederick G. 

Phrase: "In Vitro Inhibition of Insulin-Degrading Enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0877008:enzyme inhibition [Disease or Syndrome]
   774   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by Long-Chain Fatty Acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "Their Coenzyme A Thioesters Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Hamel, Jennifer L. 

Phrase: "Hamel,"

Phrase: "Jennifer L."
Processing 00000000.tx.3: Upward and Robert G. 

Phrase: "Upward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282911:Upward [Spatial Concept]

Phrase: "and"

Phrase: "Robert G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.4: Bennett Research Service (F.G.H., J.L.U., R.G.B.), Department of Veterans Affairs Medical Center, Omaha, Nebraska 68105; 

Phrase: "Bennett Research Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]

Phrase: "(F.G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0560020:g h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "J.L.U.,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Department of Veterans Affairs Medical Center,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1549054:Veterans Affairs [Organization]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0042610:Veterans [Population Group]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1704729:Department [Organization]
   766 E C3245459:veteran [Intellectual Product]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: ";"
Processing 00000000.tx.5: and Departments of Internal Medicine (F.G.H., R.G.B.) and Pharmacology (F.G.H.), University of Nebraska Medical Center, Omaha, Nebraska 68198 Address all correspondence and requests for reprints to: Frederick G. 

Phrase: "and"

Phrase: "Departments of Internal Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "(F.G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0560020:g h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "B.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "(F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68198"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.6: Hamel, Ph.D., Department of Veterans Affairs Medical Center, 4101 Woolworth Avenue, Omaha, Nebraska 68105. 

Phrase: "Hamel,"

Phrase: "Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512022:Ph.D. [Intellectual Product]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Department of Veterans Affairs Medical Center,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1549054:Veterans Affairs [Organization]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0042610:Veterans [Population Group]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1704729:Department [Organization]
   766 E C3245459:veteran [Intellectual Product]

Phrase: "4101 Woolworth Avenue,"

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]
Processing 00000000.tx.7: E-mail: fghamel{at}unmc.edu .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Insulin-degrading enzyme is responsible for initiating insulin degradation in cells, but little is known about the factors controlling its activity. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "fghamel{at}unmc.edu .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "responsible for initiating insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205309:Known [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "its activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.8: Because obesity and high levels of free fatty acids decrease insulin clearance, we examined the effect of some common free fatty acids and their acyl-coenzyme A thioesters on insulin-degrading enzyme partially purified from the livers of male Sprague Dawley rats. 

Phrase: "Because"

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "high levels of free fatty acids"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   787   C1281901:Fatty acid level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "insulin clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of some common free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "their acyl-coenzyme A thioesters on insulin-degrading enzyme partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0597572:thioester [Organic Chemical]

Phrase: "purified from the livers of male Sprague Dawley rats."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0034715:Rats, Sprague-Dawley [Mammal]
   764   C2699239:Sprague-Dawley [Mammal]
   742   C0023884:Livers [Body Part, Organ, or Organ Component]
   742   C0024554:Male [Finding]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0086582:male [Population Group]
   742   C1706180:Male [Qualitative Concept]
   742   C1706428:Male [Qualitative Concept]
   742   C1706429:Male [Organism Attribute]
   742   C1998793:Purified [Functional Concept]
   728   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   708 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   708 E C1278929:Liver [Body Part, Organ, or Organ Component]
   708 E C2346688:LIVER [Food]
Processing 00000000.tx.9: Octanoic acid (C8:0) had no effect on activity. 

Phrase: "Octanoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054616:octanoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(C8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305854:C8 [Body Location or Region]

Phrase: ":"

Phrase: "0"

Phrase: ")"

Phrase: "had"

Phrase: "no effect on activity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.10: Long-chain free fatty acids (C16C20) inhibited between 50% and 90% of the insulin degradation with IC50 values in the range of 1050 M. 

Phrase: "Long-chain free fatty acids"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   907   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   884   C0015688:Free Fatty Acids [Lipid]
   851 E C2698488:Free Fatty Acid [Laboratory Procedure]
   840   C0015684:Fatty Acids [Lipid]
   804   C0001128:Acids [Chemical]
   804   C0332296:free [Functional Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "(C16C20"

Phrase: ")"

Phrase: "inhibited between 50%"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "and"

Phrase: "90% of the insulin degradation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0243125:degradation [Functional Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with IC50 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "in the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of 1050 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.11: In general, the corresponding acyl-coenzyme A thioesters had lower IC50 values and were slightly more efficacious. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the corresponding acyl-coenzyme A thioesters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0597572:thioester [Organic Chemical]
   717   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "lower IC50 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "slightly more efficacious."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   755   C1280519:Efficacy [Qualitative Concept]
   755   C1707887:EFFICACY [Research Activity]
Processing 00000000.tx.12: 125I-insulin cross-linking studies showed free fatty acids did not inhibit hormone binding to insulin-degrading enzyme. 

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "hormone binding to insulin-degrading enzyme."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1148622:hormone binding [Molecular Function]
   783   C1149286:enzyme binding [Molecular Function]
   783   C1623517:insulin binding [Molecular Function]
   753   C0019932:Hormone [Hormone]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
Processing 00000000.tx.13: Kinetic analysis showed a noncompetitive type of inhibition. 

Phrase: "Kinetic analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a noncompetitive type of inhibition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.14: Furthermore, fatty acids eliminated the ability of insulin to inhibit the proteasome. 

Phrase: "Furthermore,"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.15: These results suggest that when intracellular long-chain fatty acid concentrations are elevated, they may act directly on insulin-degrading enzyme to decrease insulin metabolism and alter insulin action in intact cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "when"

Phrase: "intracellular long-chain fatty acid concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0086045:Concentrations [Mental Process]
   766 E C1446561:Concentration [Quantitative Concept]
   734   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   716 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: ","

Phrase: "they"

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "directly on insulin-degrading enzyme to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1947931:Directly [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "insulin metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547575:insulin metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "insulin action in intact cells."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   781   C0030281:Insulin Cell [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.16: This mechanism may contribute to the hyperinsulinemia and insulin resistance seen with elevated fatty acids and obesity.  

Phrase: "This mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "contribute to the hyperinsulinemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   770   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "seen with elevated fatty acids"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0015684:Fatty Acids [Lipid]
   760   C0001128:Acids [Chemical]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C0202406:Acid [Laboratory Procedure]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.17: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  OBESITY AND ELEVATED levels of free fatty acids (FFAs) are associated with insulin resistance and the development of type 2 diabetes mellitus. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "OBESITY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "AND"

Phrase: "ELEVATED levels of free fatty acids (FFAs)"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   787   C1281901:Fatty acid level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "the development of type 2 diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.18: One consequence of these conditions is a decrease in insulin processing. 

Phrase: "One consequence of these conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "is"

Phrase: "a decrease in insulin processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.19: Hepatic insulin clearance is reduced in overfed rats and negatively correlated with hepatic triglyceride content (1). 

Phrase: "Hepatic insulin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "reduced in overfed rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1257763:Overfed [Disease or Syndrome]

Phrase: "and"

Phrase: "negatively"

Phrase: "correlated with hepatic triglyceride content"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   760   C0205054:Hepatic [Body Location or Region]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: Similar results were found with bovine cells (2). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "found with bovine cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0007452:Bovine [Mammal]
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C1140701:bovine [Mammal]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: Severely obese humans also demonstrate decreased insulin clearance, which is significantly improved with weight loss (3). 

Phrase: "Severely obese humans also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086418:Humans [Human]

Phrase: "demonstrate"

Phrase: "decreased insulin clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "significantly"

Phrase: "improved with weight loss"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0043096:WEIGHTLOSS [Finding]
   833   C2911645:Weight loss [Finding]
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C0184511:Improved [Qualitative Concept]
   770   C0332272:Improved [Qualitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1517945:Loss [Quantitative Concept]
   770   C1561611:Improved [Intellectual Product]
   770   C1705104:Weight [Idea or Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: It is not just high tissue lipid content that is responsible for this effect; 

Phrase: "It"

Phrase: "is"

Phrase: "not just high tissue lipid content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0851043:high lipid [Finding]
   799   C0023779:Lipid [Lipid]
   799   C0423896:Content [Mental Process]
   799   C0456205:Content [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "responsible for this effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: ";"
Processing 00000000.tx.23: addition of FFAs to rat liver perfusate acutely decreased hepatic insulin removal by up to 40% (4). 

Phrase: "addition of FFAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "to rat liver perfusate acutely"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "hepatic insulin removal by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "up to 40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.24: In vivo experiments in dogs have also shown that elevated circulating FFAs decrease peripheral insulin clearance and hepatic insulin extraction (5). 

Phrase: "In vivo experiments in dogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that elevated circulating FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   884   C0015688:Free Fatty Acids [Lipid]
   851 E C2698488:Free Fatty Acid [Laboratory Procedure]
   840   C0015684:Fatty Acids [Lipid]
   804   C0001128:Acids [Chemical]
   804   C0332296:free [Functional Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "peripheral insulin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "hepatic insulin extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.25: In vitro experiments with FFAs and isolated hepatocytes have shown a decrease in insulin binding and degradation (6, 7, 8). 

Phrase: "In vitro experiments with FFAs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "isolated hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a decrease in insulin binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.26: These studies showed no effect of FFAs on partially purified insulin receptors and support the idea that receptor turnover and insulin processing were affected. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no effect of FFAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on partially purified insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that receptor turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "insulin processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158354:insulin processing [Molecular Function]
   861   C1709694:Processing [Activity]

Phrase: "were"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.27: Because insulin-degrading enzyme is the enzyme primarily responsible for initiating insulin degradation in endosomes (9), this is an obvious possible target for the action of FFAs. 

Phrase: "Because"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "primarily responsible for initiating insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "this"

Phrase: "is"

Phrase: "an obvious possible target for the action of FFAs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1521840:Target [Functional Concept]
   738   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.28: Furthermore, using the ExPASy web site (http://expasy.cbr.nrc.ca), proteomic tools for pattern and profile searches, the insulin-degrading enzyme is found to possibly possess a "cytosolic fatty-acid binding proteins signature" (Prosite access PS00214). 

Phrase: "Furthermore,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ExPASy web site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2349146:Web Site [Intellectual Product]
   827   C0205145:Site [Spatial Concept]
   827   C0282111:Web [Manufactured Object]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//expasy.cbr.nrc.ca), proteomic tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0336791:Tool [Manufactured Object]
   766   C2827396:Tool [Manufactured Object]

Phrase: "for pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "profile searches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "the insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to possibly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C2362652:Possibly [Qualitative Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a ""cytosolic fatty-acid binding proteins signature"""
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   801   C3463810:protein signature [Laboratory or Test Result]
   795   C1514562:Signature [Amino Acid Sequence]
   795   C1519316:Signature [Intellectual Product]
   795   C1705596:Signature [Idea or Concept]
   710   C0060095:Fatty Acid-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Prosite access PS00214"

Phrase: ")."
Processing 00000000.tx.29: The consensus sequence and corresponding amino acids of the rat and human insulin-degrading enzyme are shown in Fig. 

Phrase: "The consensus sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0079160:Consensus Sequence [Nucleotide Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0376298:Consensus [Social Behavior]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "corresponding amino acids of the rat"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "human insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.30: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.31: The human and rat enzymes are 66% and 77% similar to the consensus sequence. 

Phrase: "The human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "66%"

Phrase: "and"

Phrase: "77% similar to the consensus sequence."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2348205:Similar [Qualitative Concept]
   748   C1710052:Sequence Similarity [Quantitative Concept]
Processing 00000000.tx.32: If the intervening space-holding residues are included, the similarity rises to 83% and 89%, respectively. 

Phrase: "If"

Phrase: "the intervening space-holding residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "the similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similarity [Qualitative Concept]

Phrase: "rises to 83%"

Phrase: "and"

Phrase: "89%,"

Phrase: "respectively."
Processing 00000000.tx.33: This is a strong indication that insulin-degrading enzyme is capable of binding fatty acids. 

Phrase: "This"

Phrase: "is"

Phrase: "a strong indication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392360:indication [Idea or Concept]
   861   C3146298:Indication [Functional Concept]

Phrase: "that insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "capable of binding fatty acids."
Processing 00000000.tx.34: View larger version (12K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.35: Cytosolic fatty acid-binding proteins signature. 

Phrase: "Cytosolic fatty acid-binding proteins signature."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   810   C3463810:protein signature [Laboratory or Test Result]
   799   C1514562:Signature [Amino Acid Sequence]
   799   C1519316:Signature [Intellectual Product]
   799   C1705596:Signature [Idea or Concept]
   734   C0060095:Fatty Acid-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   701 E C0684153:Fatty Acid-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.36: The figure shows the 18 amino acid fatty acid-binding protein consensus sequence and the matching sequences in the rat and human insulin-degrading enzymes. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the 18 amino acid fatty acid-binding protein consensus sequence"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   883   C0002518:Amino Acid Sequence [Amino Acid Sequence]
           Protein Sequence
   807   C0079160:Consensus Sequence [Nucleotide Sequence]
   791   C0004793:Sequence [Nucleotide Sequence]
   791   C0162326:Sequence [Nucleotide Sequence]
   791   C0162327:Sequence [Nucleotide Sequence]
   791   C0376298:Consensus [Social Behavior]
   791   C1519249:Sequence [Functional Concept]
   720 E C1548958:Sequential [Idea or Concept]
   720 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "the matching sequences in the rat"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "human insulin-degrading enzymes."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   890   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   890   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.37: In the upper portion, the specific required residues are shown in capital letters and undefined residues shown as x. 

Phrase: "In the upper portion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "the specific required residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "shown in capital letters"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   816   C2827599:Capital Letter [Qualitative Concept]
   770   C0006909:Capital [Quantitative Concept]
   770   C0282413:letters [Intellectual Product]
   737 E C1096774:Letter [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
   737 E C2360551:Letter [Clinical Attribute]

Phrase: "and"

Phrase: "undefined residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "shown as x."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.38: In the lower portion, capital letters indicate the amino acids consistent with the consensus sequence, and underlined, bold letters indicate amino acids that match the specific required residues.  

Phrase: "In the lower portion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "capital letters"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C2827599:Capital Letter [Qualitative Concept]
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "indicate"

Phrase: "the amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "consistent with the consensus sequence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "underlined"

Phrase: ","

Phrase: "bold letters"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "indicate"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "match"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:match [Research Activity]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "the specific required residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.39: Insulin-degrading enzyme is not only important in insulin metabolism but also has effects on control of protein degradation. 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "not only important in insulin metabolism"

Phrase: "but"

Phrase: "also"

Phrase: "has"

Phrase: "effects on control of protein degradation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.40: We previously found that partial purification of insulin-degrading enzyme from cytosol resulted in coisolation of the proteasome, indicating a complex between proteasome and insulin-degrading enzyme (10). 

Phrase: "We previously"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that partial purification of insulin-degrading enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243114:purification [Functional Concept]
   748   C1998793:Purification [Functional Concept]

Phrase: "from cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "resulted in coisolation of the proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "indicating"

Phrase: "a complex between proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.41: We have further shown that insulin acts on this complex to inhibit two of the proteasomes catalytic activities, the chymotrypsin- and trypsin-like activities (11) with a noncompetitive type of inhibition (12). 

Phrase: "We"

Phrase: "have"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts on this complex to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "two of the proteasomes catalytic activities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "the chymotrypsin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C1150284:trypsin activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "(11"

Phrase: ")"

Phrase: "with a noncompetitive type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "of inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.42: Using a cell-permeable substrate of the proteasome, we have shown that insulin, added to HepG2 hepatoma cells, will inhibit the chymotrypsin-like activity (13, 14). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell-permeable substrate of the proteasome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "added to HepG2 hepatoma cells,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   797   C2717940:HepG2 Cells [Cell]
   773   C0677626:hepatoma cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0023903:Hepatoma [Neoplastic Process]
   760   C1524062:Added [Functional Concept]
   760   C2239176:Hepatoma [Neoplastic Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1883712:Add [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "will"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the chymotrypsin-like activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1150252:chymotrypsin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.43: The action of insulin-degrading enzyme on proteasome function applies to both the 20S and 26S forms (15). 

Phrase: "The action of insulin-degrading enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "on proteasome function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "applies to both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0185125:Apply [Health Care Activity]
   790   C1632850:Apply [Functional Concept]
   790   C1879355:Apply [Functional Concept]

Phrase: "the 20S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552134:20s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "26S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552140:26s [Body Part, Organ, or Organ Component]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.44: Thus, insulin-degrading enzyme is important in insulin action as well as hormone degradation. 

Phrase: "Thus,"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "important in insulin action"

Phrase: "as well as"

Phrase: "hormone degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157900:hormone degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.45: However, little has been published on metabolic control of insulin-degrading enzyme, with one report showing ATP could inhibit the enzyme (16). 

Phrase: "However,"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "published on metabolic control of insulin-degrading enzyme,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   770   C1513158:Metabolic Control [Molecular Function]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0034037:Published [Occupational Activity]
   744   C0243148:control [Qualitative Concept]
   744   C0311400:Metabolic [Functional Concept]
   744   C1524026:Metabolic [Cell Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1550141:Control [Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1704324:Published [Intellectual Product]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2707259:Metabolic [Clinical Attribute]
   744   C3274648:Control [Qualitative Concept]

Phrase: "with one report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "ATP"

Phrase: "could"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.46: The effect of elevated fatty acids to inhibit insulin clearance prompted us to determine whether fatty acids had any effect on insulin-degrading enzyme activity. 

Phrase: "The effect of elevated fatty acids to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "any effect on insulin-degrading enzyme activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.47: In this study we show that at physiological concentrations, FFAs, and acyl-coenzyme A (CoA) thioesters inhibit insulin-degrading enzyme degradation of insulin and alter its ability to affect proteasome activity.  

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that at physiological concentrations,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C0205463:Physiological [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "FFAs,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "acyl-coenzyme A (CoA) thioesters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0597572:thioester [Organic Chemical]
   756   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin-degrading enzyme degradation of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0678637:enzyme degradation [Laboratory Procedure]
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "proteasome activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.48: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Materials Crystalline human insulin and 125I-insulin were provided by Lilly Research Laboratories (Indianapolis, IN). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Crystalline human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "provided by Lilly Research Laboratories"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0022886:laboratories research [Research Activity]
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1619828:Laboratories [Intellectual Product]
   760   C1999230:Provided [Activity]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "(Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.49: Enzyme-grade ammonium sulfate was purchased from ICN Biomedicals, Inc. 

Phrase: "Enzyme-grade ammonium sulfate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0002611:Ammonium [Inorganic Chemical]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "purchased from ICN Biomedicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.50: (Irvine, CA). 

Phrase: "(Irvine,"

Phrase: "CA)."
Processing 00000000.tx.51: The fluorogenic peptides succinyl-leu-leu-val-tyr-7-amido-4-methyl coumarin (LLVY) and boc-leu-ser-thr-arg-7-amido-4-methyl coumarin (LSTR), fatty acids, and acyl-CoA thioesters were obtained from Sigma (St. Louis, MO). 

Phrase: "The fluorogenic peptides succinyl-leu-leu-val-tyr-7-amido-4-methyl coumarin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0010206:Cumarin [Organic Chemical,Pharmacologic Substance]

Phrase: "(LLVY"

Phrase: ")"

Phrase: "and"

Phrase: "boc-leu-ser-thr-arg-7-amido-4-methyl coumarin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010206:Cumarin [Organic Chemical,Pharmacologic Substance]

Phrase: "(LSTR"

Phrase: ")"

Phrase: ","

Phrase: "fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "acyl-CoA thioesters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0597572:thioester [Organic Chemical]
   756   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.52: All other chemicals were of at least reagent grade. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were of"

Phrase: "at least reagent grade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441800:Grade [Classification]
   827   C0919553:Grade [Classification]
   827   C3244287:grade [Finding]
Processing 00000000.tx.53: Enzyme preparation Male Sprague Dawley rats were maintained and used in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, under a protocol approved by the Subcommittee of Animal Studies and the Research and Development Committee of the Omaha Veterans Affairs Medical Center. 

Phrase: "Enzyme preparation Male Sprague Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034715:Rats, Sprague-Dawley [Mammal]
   827   C2699239:Sprague-Dawley [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "used in accordance with the National Institutes of Health Guide"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   806   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   741   C1524063:Use of [Functional Concept]
   739   C0018684:Health [Idea or Concept]
   739   C0021622:Institutes [Organization]
   739   C0181090:Guide [Professional or Occupational Group]
   739   C0302614:Guide [Medical Device]
   739   C1273517:used [Finding]
   739   C1706050:Guide [Manufactured Object]
   739   C3245503:national [Intellectual Product]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706 E C1272753:Institute [Idea or Concept]
   706 E C1947944:Use [Intellectual Product]

Phrase: "for the Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use of Laboratory Animals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "under a protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "approved by the Subcommittee of Animal Studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0683949:animal studies [Animal]
   748   C0003062:Animal [Animal]
   748   C0205540:Approved [Qualitative Concept]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the Research and Development Committee of the Omaha Veterans Affairs Medical Center."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C2699414:Committee [Group]
Processing 00000000.tx.54: Insulin-degrading enzyme/proteasome was prepared from rat liver by ultracentrifugation, ammonium sulfate precipitation, and diethylaminoethyl-Sephacel batch elution similar to that described previously (17). 

Phrase: "Insulin-degrading enzyme/proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1325620:proteasome [Cell Component]
   812   C1752727:Proteasome [Molecular Function]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "prepared from rat liver"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737   C1521827:Prepare [Functional Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "by ultracentrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041609:Ultracentrifugation [Laboratory Procedure]

Phrase: "ammonium sulfate precipitation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0032931:Precipitation [Natural Phenomenon or Process]
   827   C0032932:Precipitation [Molecular Function]
   827   C1642401:% precipitation [Quantitative Concept]
   827   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "diethylaminoethyl-Sephacel batch elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1441565:Elution [Laboratory Procedure]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.55: Assay of insulin degradation The degradation of 125I-insulin was measured by the trichloroacetic acid (TCA) solubility assay (17). 

Phrase: "Assay of insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "The degradation of 125I-insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured by the trichloroacetic acid (TCA) solubility assay"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0037628:Solubility [Qualitative Concept]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.56: Fatty acids were dissolved in ethanol and added at the indicated concentrations. 

Phrase: "Fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "dissolved in ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   756   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "added at the indicated concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0086045:Concentrations [Mental Process]
   760   C1444656:Indicated [Finding]
   760   C1524062:Added [Functional Concept]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.57: The final concentration of ethanol was 1% (vol/vol), which altered insulin-degrading enzyme activity by less than 10%. 

Phrase: "The final concentration of ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(vol/vol),"

Phrase: "which"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "insulin-degrading enzyme activity by less"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243102:enzyme activity [Molecular Function]
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "than 10%."
Processing 00000000.tx.58: Briefly, an enzyme aliquot was incubated with 125I-[A14]-iodoinsulin in 1 ml Tris (pH 7.4) for 15 min at 37 C. 

Phrase: "Briefly,"

Phrase: "an enzyme aliquot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "[A14"

Phrase: "]-iodoinsulin in 1 ml Tris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0063651:insulin, iodo- [Amino Acid, Peptide, or Protein]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C."
Processing 00000000.tx.59: The reaction was stopped by addition of 0.5% (final) BSA and 10% (final) TCA. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by addition of 0.5%"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444499:0/5 [Quantitative Concept]
   753   C1272691:stopped [Qualitative Concept]
   753   C1883712:Addition [Functional Concept]
   719 E C1947925:Stop [Activity]
   719 E C2746065:Stop [Temporal Concept]

Phrase: "(final"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205088:Final [Temporal Concept]
  1000   C1546485:Final [Idea or Concept]

Phrase: ")"

Phrase: "BSA"

Phrase: "and"

Phrase: "10%"

Phrase: "(final"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205088:Final [Temporal Concept]
  1000   C1546485:Final [Idea or Concept]

Phrase: ")"

Phrase: "TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.60: The samples were centrifuged and the supernatant and pellet counted on a counter. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "counted on a counter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0677601:Counter [Manufactured Object]
   770   C1705206:Counter [Medical Device]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.61: Qualitative analysis of the products formed was done by HPLC as described previously (18). 

Phrase: "Qualitative analysis of the products"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205556:Qualitative [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "done by HPLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.62: Covalent cross-linking of 125I-insulin to insulin-degrading enzyme Preparations of partially purified insulin-degrading enzyme were covalently cross-linked to 125I-insulin using the homobifunctional amine-reactive cross-linker disuccininmidyl suberate (Pierce Chemical Co., Rockford, IL) by a procedure described previously (19). 

Phrase: "Covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking of 125I-insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to insulin-degrading enzyme Preparations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0021641:INSULIN PREPARATIONS [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0360722:ENZYME PREPARATIONS [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "of partially purified insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "covalently"

Phrase: "cross-linked to 125I-insulin"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0178576:Cross Linked [Natural Phenomenon or Process]
   806   C0332220:cross linked [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the homobifunctional amine-reactive cross-linker disuccininmidyl suberate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0947344:Suberate [Organic Chemical]

Phrase: "(Pierce Chemical Co.,"

Phrase: "Rockford,"

Phrase: "IL) by a procedure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020898:IL [Geographic Area]
   770   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0022271:IL [Geographic Area]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.63: Assay of proteasome activity The proteasome has a number of peptidolytic activities, which can be assayed by the cleavage of fluorogenic peptides. 

Phrase: "Assay of proteasome activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "has"

Phrase: "a number of peptidolytic activities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "assayed by the cleavage of fluorogenic peptides."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0010813:cleavage [Cell Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.64: The degradation of LLVY and LSTR were used as measures of the chymotrypsin-like and trypsin-like activities, respectively, as described previously (11). 

Phrase: "The degradation of LLVY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "LSTR"

Phrase: "were"

Phrase: "used as measures of the chymotrypsin-like"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C1413809:chymotrypsin-like [Gene or Genome]
   757   C1524063:Use of [Functional Concept]
   748   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0079809:Measures [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C1879489:Measures [Functional Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "trypsin-like activities,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C1150284:trypsin activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "respectively,"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.65: The enzyme sample was incubated with 13 M LLVY or LSTR in 1 ml 100 mM Tris (pH 7.5), with additions as noted, for 1 h. 

Phrase: "The enzyme sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "incubated with 13 M LLVY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "LSTR in 1 ml 100 mM Tris"

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "with additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: "as"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.66: The reaction was stopped with 0.2 ml ice cold ethanol and activity expressed as the change in fluorescence over time (excitation and emission wavelengths of 390 nm and 440 nm, respectively). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with 0.2 ml ice cold ethanol"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0456963:Ice cold [Qualitative Concept]
   744   C0001962:Ethanol [Organic Chemical]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0234192:Cold [Physiologic Function]
   744   C0439526:/mL [Quantitative Concept]
   744   C1272691:stopped [Qualitative Concept]
   711 E C1947925:Stop [Activity]
   711 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "expressed as the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths of 390 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449819:wavelengths [Quantitative Concept]

Phrase: "and"

Phrase: "440 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.67: Data analysis All data are shown as mean  SEM. 

Phrase: "Data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown as mean  SEM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.68: The IC50s and maximal effect were determined by fitting the data to a one-site competition model with nonlinear regression using GraphPad Prism (version 3.02 for Windows, GraphPad Software, Inc., San Diego, CA). 

Phrase: "The IC50s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0600495:IC50 [Quantitative Concept]

Phrase: "and"

Phrase: "maximal effect"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205289:Maximal [Qualitative Concept]
   861   C0806909:Maximal [Quantitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   789 E C1552615:maximum [Quantitative Concept]
   789 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "were"

Phrase: "determined by fitting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036572:Fitting [Sign or Symptom]
   790   C0441548:Fitting [Health Care Activity]

Phrase: "the data to a one-site competition model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]

Phrase: "with nonlinear regression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GraphPad Prism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0814195:PRISM [Intellectual Product]
   805 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(version 3.02 for Windows,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0333052:Version [Functional Concept]
   760   C0557702:windows [Manufactured Object]
   760   C2607870:Version [Spatial Concept]
   726 E C1272706:Window [Temporal Concept]
   726 E C1704674:Window [Manufactured Object]

Phrase: "GraphPad Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "Inc.,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.69: Means were compared by ANOVA with Dunnetts multiple comparison posttest. 

Phrase: "Means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "were"

Phrase: "compared by ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "with Dunnetts multiple comparison posttest."
Processing 00000000.tx.70: The Dixon plot data were analyzed by fitting the data with linear regression.  

Phrase: "The Dixon plot data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by fitting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036572:Fitting [Sign or Symptom]
   790   C0441548:Fitting [Health Care Activity]
   790   C0936012:Analyzed [Research Activity]

Phrase: "the data with linear regression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
Processing 00000000.tx.71: Results Top Abstract Introduction Materials and Methods Results Discussion References  Figure 2 shows the inhibition of insulin-degrading enzyme by selected fatty acids and fatty acyl CoA thioesters. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Figure"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0877008:enzyme inhibition [Disease or Syndrome]
   783   C1524081:Enzyme Inhibition [Physiologic Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by selected fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "fatty acyl CoA thioesters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0597572:thioester [Organic Chemical]
   717   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.72: Table 1 shows IC50 values and the maximal amount of inhibition by all the compounds tested. 

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "IC50 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the maximal amount of inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "by all"

Phrase: "the compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.73: Octanoic acid, acetyl-CoA, malonyl-CoA, and lactic acid had no effect. 

Phrase: "Octanoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054616:octanoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "acetyl-CoA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001026:Acetyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
           acetyl coenzyme
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "malonyl-CoA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024645:Malonyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "lactic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0064582:Lactic acid [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.74: Palmitic acid (16:0), palmitoleic acid (16:1), arachidonic acid (20:4), arachidonoyl-CoA, and docosahexaenoic acid (22:6) had substantial effects but only at the highest concentrations tested. 

Phrase: "Palmitic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030234:Palmitic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(16"

Phrase: ":"

Phrase: "0"

Phrase: ")"

Phrase: ","

Phrase: "palmitoleic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069966:palmitoleic acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(16"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(20"

Phrase: ":"

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "arachidonoyl-CoA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052297:arachidonoyl-coenzyme A [Biologically Active Substance,Organic Chemical]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "docosahexaenoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012968:docosahexaenoic acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0556150:docosahexaenoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(22"

Phrase: ":"

Phrase: "6"

Phrase: ")"

Phrase: "had"

Phrase: "substantial effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "only at the highest concentrations"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0205171:Only [Quantitative Concept]
   760   C1522410:Highest [Qualitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.75: The C18 unsaturated FFAs were the most potent of those we tested. 

Phrase: "The C18 unsaturated FFAs"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   921   C2700114:Free Fatty Acid, Unsaturated [Laboratory Procedure]
   888   C0015690:Fatty Acids, Unsaturated [Lipid]
   884   C0015688:Free Fatty Acids [Lipid]
   851 E C2698488:Free Fatty Acid [Laboratory Procedure]
   840   C0015684:Fatty Acids [Lipid]
   804   C0001128:Acids [Chemical]
   804   C0332296:free [Functional Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "the most potent of those"

Phrase: "we"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.76: Although the addition of the CoA group to arachidonic acid did not increase its effectiveness, linoleoyl-CoA, oleoyl-CoA, and especially palmitoyl-CoA were more effective than their respective FFAs. 

Phrase: "Although"

Phrase: "the addition of the CoA group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "to arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "its effectiveness,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280519:Effectiveness [Qualitative Concept]
   928 E C1704419:Effective [Qualitative Concept]

Phrase: "linoleoyl-CoA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0065018:linoleoyl-coenzyme A [Lipid]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "oleoyl-CoA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069407:oleoyl-coenzyme A [Biologically Active Substance,Lipid]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "especially palmitoyl-CoA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "were"

Phrase: "more effective than their respective FFAs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280519:effective [Qualitative Concept]
   744   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.77: View larger version (20K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.78: Inhibition of insulin-degrading enzyme by fatty acid and fatty acyl CoA thioesters. 

Phrase: "Inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0877008:enzyme inhibition [Disease or Syndrome]
   797   C1524081:Enzyme Inhibition [Physiologic Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by fatty acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015684:Fatty acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "fatty acyl CoA thioesters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0597572:thioester [Organic Chemical]
   717   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.79: The effect of octanoic acid (n = 4), palmititic acid, (n = 4), palmitoyl-CoA (n = 4), linoleic acid, (n = 5), and linoleoyl-CoA (n = 4) on insulin-degrading activity are shown as indicated. 

Phrase: "The effect of octanoic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "palmititic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "palmitoyl-CoA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "linoleic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023749:Linoleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "linoleoyl-CoA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0065018:linoleoyl-coenzyme A [Lipid]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "on insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.80: The data are expressed as a ratio to degradation with vehicle (ethanol) alone.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as a ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "to degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "with vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "(ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001962:Ethanol [Organic Chemical]

Phrase: ")"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.81: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.82: IC50 and maximal inhibition of tested compounds  We also tested, by HPLC analysis, the qualitative effect of FFAs on the generation of insulin products. 

Phrase: "IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "and"

Phrase: "maximal inhibition of tested compounds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0201783:Inhibition test [Laboratory Procedure]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "by HPLC analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "the qualitative effect of FFAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of insulin products."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.83: Figure 3 shows representative elution profiles of A14-iodoinsulin fragments after incubation with insulin-degrading enzyme in the absence and presence of linoleic acid. 

Phrase: "Figure 3"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative elution profiles of A14-iodoinsulin fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1979963:Profile [Laboratory Procedure]
   714   C2003903:Profile [Functional Concept]

Phrase: "after incubation"

Phrase: "with insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "presence of linoleic acid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.84: The product patterns were very similar, with no major products missing or additional peaks arising from the inclusion of linoleic acid. 

Phrase: "The product patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "very similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: "with no major products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "or"

Phrase: "additional peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "arising from the inclusion of linoleic acid."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0023749:Linoleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0332284:arising [Qualitative Concept]
   748   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.85: The first three peaks were reduced with the FFA-treated enzyme, which would account for the small difference in TCA solubility between the two samples (4.6% vs. 3.6%, control vs. linoleic acid). 

Phrase: "The first three peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "reduced with the FFA-treated enzyme,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   800   C0015688:Free Fatty Acids [Lipid]
   770   C0015684:Fatty Acids [Lipid]
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   767 E C2698488:Free Fatty Acid [Laboratory Procedure]
   744   C0001128:Acids [Chemical]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0332296:free [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "which"

Phrase: "would"

Phrase: "account for the small difference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0700321:Small [Quantitative Concept]
   760   C1551359:account [Idea or Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "in TCA solubility"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037628:Solubility [Qualitative Concept]
   755 E C1749467:soluble [Cell Component]
   755 E C1948047:Soluble [Qualitative Concept]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]

Phrase: "between the two samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(4.6%"

Phrase: "vs. 3.6%,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442759:3 6 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "vs. linoleic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023749:Linoleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.86: These preliminary results suggest that FFAs do not alter the enzymes preference for the various cleavage sites but generally decrease degradation. 

Phrase: "These preliminary results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the enzymes preference for the various cleavage sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0558295:preference [Idea or Concept]
   744   C1549513:Preference [Idea or Concept]

Phrase: "but"

Phrase: "generally"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.87: View larger version (19K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.88: HPLC analysis of insulin degradation products in the presence and absence of linoleic acid. 

Phrase: "HPLC analysis of insulin degradation products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of linoleic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.89: The figure shows a representative chromatograph of 125I-insulin incubated with partially purified insulin-degrading enzyme for 15 min in the presence or absence of 100 M linoleic acid. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a representative chromatograph of 125I-insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0302647:chromatograph [Medical Device]

Phrase: "incubated with partially purified insulin-degrading enzyme"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1998793:Purified [Functional Concept]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 100 M linoleic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.90: The experiment was performed at least nine times, with TCA solubility varying from 3% to 30% and using three independent enzyme preparations. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed at least nine times,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205455:Nine [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with TCA solubility"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037628:Solubility [Qualitative Concept]
   755 E C1749467:soluble [Cell Component]
   755 E C1948047:Soluble [Qualitative Concept]
   734   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]

Phrase: "varying from 3%"

Phrase: "to 30%"

Phrase: "and"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three independent enzyme preparations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0360722:ENZYME PREPARATIONS [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.91: Similar results have been obtained with palmitoyl-CoA.  

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "obtained with palmitoyl-CoA."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   862   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.92: To examine the nature of the inhibition, we cross-linked insulin to insulin-degrading enzyme in the absence and presence of linoleic acid and linoleoyl-CoA. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the nature of the inhibition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "we"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "insulin to insulin-degrading enzyme"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "presence of linoleic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "linoleoyl-CoA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0065018:linoleoyl-coenzyme A [Lipid]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.93: Figure 4 shows a sample autoradiograph of the 110-kDa band (the molecular weight of insulin-degrading enzyme) and quantification by densitometry. 

Phrase: "Figure 4"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a sample autoradiograph of the 110-kDa band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986957:Autoradiograph [Manufactured Object]

Phrase: "("

Phrase: "the molecular weight of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0026385:Molecular Weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1705104:Weight [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "quantification by densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]
Processing 00000000.tx.94: Interestingly, neither compound significantly suppressed cross-linking, and in fact there appears to be a small increase. 

Phrase: "Interestingly,"

Phrase: "neither compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "significantly suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1260953:Suppressed [Functional Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ","

Phrase: "and in fact there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a small increase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]
Processing 00000000.tx.95: Similar results were seen with other FFAs (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "seen with other FFAs"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0015688:Free Fatty Acids [Lipid]
   799 E C2698488:Free Fatty Acid [Laboratory Procedure]
   790   C0015684:Fatty Acids [Lipid]
   753   C0001128:Acids [Chemical]
   753   C0205397:Seen [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C0202406:Acid [Laboratory Procedure]
   719 E C1947903:See [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: This indicates that FFAs inhibit degradation without disrupting binding and suggests a noncompetitive inhibition. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "degradation without disrupting binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a noncompetitive inhibition."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0301627:Noncompetitive inhibition [Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.97: Analysis of FFA inhibition by Dixon plot confirms this conclusion (Fig. 5). 

Phrase: "Analysis of FFA inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "by Dixon plot"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.98: The inhibitory constants for linoleic acid and palmitoyl-CoA were 23  3 and 15  1 M, respectively. 

Phrase: "The inhibitory constants for linoleic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1547014:*Constant [Quantitative Concept]
   719   C1948059:Constant [Qualitative Concept]

Phrase: "and"

Phrase: "palmitoyl-CoA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "were"

Phrase: "23  3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "and"

Phrase: "15  1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "respectively."
Processing 00000000.tx.99: View larger version (33K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.100: Effect of linoleic acid and linoleoyl-CoA on 125I-insulin cross-linking to insulin-degrading enzyme. 

Phrase: "Effect of linoleic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "linoleoyl-CoA on 125I-insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0065018:linoleoyl-coenzyme A [Lipid]
   790   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "cross-linking to insulin-degrading enzyme."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   790   C0332220:Cross-linking [Functional Concept]
   773 E C0178576:Cross link [Natural Phenomenon or Process]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.101: A, A representative autoradiograph showing the effect of 10 M or 100 M linoleic acid and linoleoyl-CoA on the cross-linking of 125I-insulin to insulin-degrading enzyme. 

Phrase: "A,"

Phrase: "A representative autoradiograph"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2986957:Autoradiograph [Manufactured Object]
   761 E C0004400:Autoradiography [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the effect of 10 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "100 M linoleic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023749:Linoleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "linoleoyl-CoA on the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0065018:linoleoyl-coenzyme A [Lipid]
   806   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "cross-linking of 125I-insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.102: Inhibition of cross-linking by 1 M unlabeled insulin is shown as a control. 

Phrase: "Inhibition of"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0021467:Inhibition [Mental Process]
   833   C0021469:Inhibition [Molecular Function]
   833   C1628982:% inhibition [Quantitative Concept]
   833   C3463820:Inhibition [Activity]
   761 E C0311403:Inhibited [Qualitative Concept]

Phrase: "cross-linking by 1 M unlabeled insulin"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0332220:Cross-linking [Functional Concept]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "is"

Phrase: "shown as a control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: B, The densitometric analysis of six independent experiments. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The densitometric analysis of six independent experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.104: *, P < 0.05, compared with 125I-insulin alone.  

Phrase: "*,"

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with 125I-insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707455:Compared [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.105: View larger version (12K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.106: Dixon plots of linoleic acid and palmitoyl-CoA inhibition of insulin-degrading enzyme. 

Phrase: "Dixon"

Phrase: "plots of linoleic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0023749:Linoleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "palmitoyl-CoA inhibition of insulin-degrading enzyme."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0877008:enzyme inhibition [Disease or Syndrome]
   767   C1524081:Enzyme Inhibition [Physiologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.107: The data are plotted as the inverse of the velocity vs. the concentration of inhibitor (linoleic acid, A, or palmitoyl-CoA, B) and represent the means of three experiments. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as the inverse of the velocity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439830:Velocity [Quantitative Concept]
   748   C0439850:Inverse [Qualitative Concept]
   748   C1547053:*Velocity [Quantitative Concept]

Phrase: "vs."

Phrase: "the concentration of inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "(linoleic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023749:Linoleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "A,"

Phrase: "or"

Phrase: "palmitoyl-CoA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means of three experiments."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.108: The lines show the results of linear regression of the data. 

Phrase: "The lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results of linear regression of the data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.109: The inhibitory constants were determined by the x-intercept.  

Phrase: "The inhibitory constants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "were"

Phrase: "determined by the x-"

Phrase: "intercept."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0598981:Intercept [Organic Chemical,Pharmacologic Substance]
  1000   C3146232:Intercept [Quantitative Concept]
Processing 00000000.tx.110: We have previously shown that insulin will decrease the chymotrypsin- and trypsin-like activities of the proteasome when it is isolated in a complex with insulin-degrading enzyme. 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "will"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the chymotrypsin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities of the proteasome"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C1150284:trypsin activity [Molecular Function]
   767   C1622946:proteasome activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "it"

Phrase: "is"

Phrase: "isolated in a complex"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205409:Isolated [Functional Concept]
   770   C0439855:Complex [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.111: We tested whether fatty acids would have an effect on this inhibition. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "would"

Phrase: "have"

Phrase: "an effect on this inhibition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.112: Figure 6 shows that increasing concentrations of fatty acid inhibit the chymotrypsin-like and trypsin-like activities of the proteasome and insulin will not further decrease those activities. 

Phrase: "Figure 6"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that increasing concentrations of fatty acid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the chymotrypsin-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413809:chymotrypsin-like [Gene or Genome]
   861   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities of the proteasome"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C1150284:trypsin activity [Molecular Function]
   767   C1622946:proteasome activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "will"

Phrase: "not further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1518422:Not [Functional Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "those activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.113: Thus, in the presence of fatty acids, the ability of insulin to inhibit the proteasome is lost. 

Phrase: "Thus,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "lost."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]
Processing 00000000.tx.114: View larger version (13K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.115: Loss of insulin-responsive proteasome activity by palmitoyl-CoA. 

Phrase: "Loss of insulin-responsive proteasome activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "by palmitoyl-CoA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.116: The graph shows the effect of increasing concentrations of palmitoyl-CoA on the chymotrypsin-like (A, n = 4) and trypsin-like (B, n = 4) activities of the proteasome. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the effect of increasing concentrations of palmitoyl-CoA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on the chymotrypsin-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413809:chymotrypsin-like [Gene or Genome]
   861   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(A,"

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "trypsin-like"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "activities of the proteasome."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C1622946:proteasome activity [Molecular Function]
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.117: Open and closed circles show the effect in the absence and presence of 1 M insulin, respectively. 

Phrase: "Open"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]
   928 E C0547049:Openness [Spatial Concept]

Phrase: "and"

Phrase: "closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the effect in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "presence of 1 M insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "respectively."
Processing 00000000.tx.118: High concentrations of palmitoyl-CoA do not inhibit the proteasome more than insulin alone. 

Phrase: "High concentrations of palmitoyl-CoA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the proteasome more than insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.119: The data are expressed as a ratio to degradation with vehicle alone.   

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as a ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "to degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "with vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.120: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Our data show that FFAs and related acyl-CoA thioesters can inhibit the actions of insulin-degrading enzyme. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "related acyl-CoA thioesters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0597572:thioester [Organic Chemical]
   717   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the actions of insulin-degrading enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441472:actions [Functional Concept]
   719 E C3266814:Action [Activity]
Processing 00000000.tx.121: This inhibition has implications for two aspects of obesity and diabetes, hyperinsulinemia and insulin resistance. 

Phrase: "This inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "has"

Phrase: "implications for two aspects of obesity"

Phrase: "and"

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.122: Elevated lipids and FFAs have been shown to affect insulin processing at the cellular level (6, 7, 8) as well as insulin clearance in whole animals (1, 2, 3, 4, 5). 

Phrase: "Elevated lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "and"

Phrase: "FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin processing at the cellular level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1158354:insulin processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8"

Phrase: ")"

Phrase: "as well as"

Phrase: "insulin clearance in whole animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.123: Our studies show FFAs noncompetitively inhibit insulin-degrading enzyme without changing the products produced. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "FFAs noncompetitively"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin-degrading enzyme without changing"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "produced."
Processing 00000000.tx.124: In the Zucker fatty rat model, palmitoyl-CoA levels are doubled in livers and muscles (20) to a level that would correlate to about a 50% increase in inhibition of insulin-degrading enzyme, based on our data. 

Phrase: "In the Zucker fatty rat model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3161035:Model [Intellectual Product]
   708   C0034719:Zucker rat [Mammal]

Phrase: "palmitoyl-CoA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756   C0030239:Palmitoyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "doubled in livers"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   790   C0023884:Livers [Body Part, Organ, or Organ Component]
   790   C0205173:doubled [Functional Concept]
   756 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   756 E C1278929:Liver [Body Part, Organ, or Organ Component]
   756 E C1705764:Double [Activity]
   756 E C1705765:Double [Qualitative Concept]
   756 E C2346688:LIVER [Food]
   718 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "to a level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "would"

Phrase: "correlate"

Phrase: "to about"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "a 50% increase in inhibition of insulin-degrading enzyme,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0020459:INSULIN INCREASE [Disease or Syndrome]
   742   C0442805:Increase [Functional Concept]

Phrase: "based on our data."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.125: Because insulin-degrading enzyme is responsible for initiating insulin degradation in endosomes (9), impairment of its action could be responsible for decreased clearance and thereby contribute to the hyperinsulinemia found in insulin-resistant and diabetic conditions in animals and humans. 

Phrase: "Because"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "responsible for initiating insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "impairment of its action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684336:Impairment [Pathologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "responsible for decreased clearance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "thereby"

Phrase: "contribute to the hyperinsulinemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   770   C1880177:Contribute [Activity]

Phrase: "found in insulin-resistant"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0150312:Found [Quantitative Concept]
   770   C0332325:Resistant [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2827757:RESISTANT [Laboratory or Test Result]
   737 E C0243095:Find [Finding]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetic conditions in animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.126: The inhibition of insulin-degrading enzyme by FFAs may also represent a physiological control mechanism. 

Phrase: "The inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0877008:enzyme inhibition [Disease or Syndrome]
   783   C1524081:Enzyme Inhibition [Physiologic Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "also"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a physiological control mechanism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0441712:Mechanism [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706376:Mechanism [Manufactured Object]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.127: The FFA concentrations that show significant, though not complete, inhibition are in the low micromolar range. 

Phrase: "The FFA concentrations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   756   C0015688:Free Fatty Acids [Lipid]
   729 E C1880165:Concentrated [Biomedical or Dental Material]
   723 E C2698488:Free Fatty Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "significant,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "though"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: ","

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "are in the low micromolar range."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205251:low [Qualitative Concept]
   753   C0439300:micromolar [Quantitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C1550472:low [Idea or Concept]
   753   C1551058:Are [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]
Processing 00000000.tx.128: The IC50s of the most potent compounds are around 10 M, a concentration that is within physiological range and shows similar inhibition of hexokinase (21). 

Phrase: "The IC50s of the most potent compounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0600495:IC50 [Quantitative Concept]

Phrase: "are around 10 M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1551058:Are [Quantitative Concept]

Phrase: "a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "that"

Phrase: "is within physiological range"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205463:Physiological [Functional Concept]
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "similar inhibition of hexokinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.129: Postprandial absorption of FFAs could easily achieve these levels in the liver, decreasing liver clearance and adding to the rise of peripheral insulin concentrations. 

Phrase: "Postprandial absorption of FFAs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0000854:Absorption [Natural Phenomenon or Process]
   753   C0220777:absorption [Functional Concept]
   753   C2347023:Absorption [Phenomenon or Process]
   753   C2347080:Absorption [Phenomenon or Process]
   753   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   753   C2825050:Absorption [Phenomenon or Process]

Phrase: "could"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "achieve"

Phrase: "these levels in the liver,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "liver clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "adding to the rise of peripheral insulin concentrations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1883712:Add [Functional Concept]
Processing 00000000.tx.130: Thus, FFAs are a likely metabolic control for the action of insulin-degrading enzyme. 

Phrase: "Thus,"

Phrase: "FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "a likely metabolic control for the action of insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C1513158:Metabolic Control [Molecular Function]
   738   C0243148:control [Qualitative Concept]
   738   C0311400:Metabolic [Functional Concept]
   738   C1524026:Metabolic [Cell Function]
   738   C1550141:Control [Substance]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C2707259:Metabolic [Clinical Attribute]
   738   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.131: However, insulin-degrading enzyme has functions beyond simply degrading hormones, and interruption of its actions could have implications in hormone action and signal transduction and thus insulin resistance. 

Phrase: "However,"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "functions beyond simply degrading hormones,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0682760:function hormones [Hormone]
   760   C0019932:Hormones [Hormone]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "interruption of its actions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332453:interruption [Functional Concept]
   770   C1512900:Interruption [Temporal Concept]

Phrase: "could"

Phrase: "have"

Phrase: "implications in hormone action"

Phrase: "and"

Phrase: "signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "thus insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.132: Internalization and processing of insulin are necessary for insulin effects on cellular protein degradation and amino acid transport but not insulin-stimulated glycogen synthesis (22, 23, 24). 

Phrase: "Internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "processing of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1158354:insulin processing [Molecular Function]
   790   C1709694:Processing [Activity]

Phrase: "are"

Phrase: "necessary for insulin effects"

Phrase: "on cellular protein degradation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1523944:cellular protein degradation [Cell Function]
   913   C1523935:cellular degradation [Cell Function]
   901   C0597297:Protein Degradation [Molecular Function]
   901   C0597304:Protein Degradation [Molecular Function]
   901   C1623036:Protein Degradation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "amino acid transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0596078:amino acid transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "but"

Phrase: "not insulin-stimulated glycogen synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1157202:glycogen synthesis [Molecular Function]
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]

Phrase: "(22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.133: Intracellular insulin, internalized by linking to ricin molecules or microinjection, has biological effects (25, 26, 27, 28). 

Phrase: "Intracellular insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "internalized by linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "to ricin molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "or"

Phrase: "microinjection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025991:Microinjection [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "biological effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(25,"

Phrase: "26,"

Phrase: "27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.134: It has also been shown that insulin can be internalized and transported to the nucleus, and insulin-degrading enzyme is one of the proteins involved (29, 30, 31, 32). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "internalized"

Phrase: "and"

Phrase: "transported to the nucleus,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C1550030:Transport To [Idea or Concept]
   802   C1526989:nucleus transport [Cell Function]
   770   C0007610:Nucleus [Cell Component]
   737   C0005528:Transport, NOS [Cell Function]
   737   C1317949:Transport [Manufactured Object]
   737   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "one of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "(29,"

Phrase: "30,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.135: The intracellular receptors for androgens and glucocorticoids form a complex with insulin-degrading enzyme that increases their activities (33, 34). 

Phrase: "The intracellular receptors for androgens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0034786:Receptors, Androgens [Amino Acid, Peptide, or Protein,Receptor]
   764 E C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a complex with insulin-degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.136: Addition of insulin to the insulin-degrading enzyme-steroid receptor complex decreases the receptors binding of DNA, which agrees with the physiological effect of insulin. 

Phrase: "Addition of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "to the insulin-degrading enzyme-steroid receptor complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   904   C1167226:insulin receptor complex [Cell Component]
   858   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1523873:receptor complex [Cell Component]
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]
   709   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   709   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "binding of DNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1148673:DNA Binding [Genetic Function]
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "which"

Phrase: "agrees with the physiological effect of insulin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205463:Physiological [Functional Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2348382:Effect [Qualitative Concept]
   748   C3641827:Agree [Intellectual Product]
Processing 00000000.tx.137: We have similarly shown insulin-degrading enzyme forms a complex with the proteasome that increases peptidolytic activity (10, 11, 15, 35). 

Phrase: "We"

Phrase: "have"

Phrase: "similarly"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a complex with the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "peptidolytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(10,"

Phrase: "11,"

Phrase: "15,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.138: Insulin acts on this complex to cause the dissociation of insulin-degrading enzyme, noncompetitively decreasing two of the proteasomes catalytic activities. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts on this complex to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the dissociation of insulin-degrading enzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "noncompetitively"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "two of the proteasomes catalytic activities."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]
Processing 00000000.tx.139: These data all support interactions among insulin, insulin-degrading enzyme, and various cytosolic proteins and raise the possibility of an intracellular site of action for insulin (36, 37). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "all"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "interactions among insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "insulin-degrading enzyme,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "various cytosolic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "raise"

Phrase: "the possibility of an intracellular site of action"

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.140: We have shown here that at least one of these interactions, with the proteasome, is affected by FFAs. 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that at least one of these interactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205447:One [Quantitative Concept]
   714   C1704675:Interaction [Functional Concept]

Phrase: "with the proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "affected by FFAs."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0015688:Free Fatty Acids [Lipid]
   828 E C2698488:Free Fatty Acid [Laboratory Procedure]
   806   C0015684:Fatty Acids [Lipid]
   760   C0001128:Acids [Chemical]
   760   C0332296:free [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0001721:Affect [Mental Process]
   726 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.141: In the absence of insulin, increasing concentrations of palmitoyl-CoA decrease the activity of the proteasome down to the level of that found with maximal inhibition by insulin (1 M). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "concentrations of palmitoyl-CoA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the activity of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1622946:proteasome activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "down"

Phrase: "to the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of that"

Phrase: "found with maximal inhibition"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0150312:Found [Quantitative Concept]
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737 E C0243095:Find [Finding]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)."
Processing 00000000.tx.142: We believe that binding of the fatty acid, like that of insulin, causes a dissociation of insulin-degrading enzyme from the proteasome, decreasing peptidolytic activity. 

Phrase: "We"

Phrase: "believe"

Phrase: "that binding of the fatty acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1148641:fatty acid binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "like that"

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a dissociation of insulin-degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from the proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "peptidolytic activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.143: Insulin and FFAs are not additive, suggesting a similar mechanism. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "not additive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442796:Additive [Qualitative Concept]
   861   C1550602:Additive [Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a similar mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.144: In metabolic states in which FFAs are increased, protein degradation would be decreased, and, more importantly, the ability of insulin to alter protein degradation via the proteasome would be abrogated. 

Phrase: "In metabolic states"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0311400:Metabolic [Functional Concept]
   861   C1301808:states [Geographic Area]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "in which FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "would"

Phrase: "be"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "more importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "protein degradation via the proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0597297:Protein Degradation [Molecular Function]
   806   C0597304:Protein Degradation [Molecular Function]
   806   C1623036:Protein Degradation [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "would"

Phrase: "be"

Phrase: "abrogated."
Processing 00000000.tx.145: Because insulins major effect on protein metabolism is to decrease protein degradation, this would be a form of insulin resistance. 

Phrase: "Because"

Phrase: "insulins major effect on protein metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "protein degradation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "this"

Phrase: "would"

Phrase: "be"

Phrase: "a form of insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.146: Thus, FFA inhibition of insulin-degrading enzyme may contribute to insulin resistance by disrupting control of protein metabolism. 

Phrase: "Thus,"

Phrase: "FFA inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0877008:enzyme inhibition [Disease or Syndrome]
   767   C1524081:Enzyme Inhibition [Physiologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "may"

Phrase: "contribute to insulin resistance"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C0332325:Resistant to [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1880177:Contribute [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by disrupting control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "of protein metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597299:Protein Metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.147: Although speculative, the possible implications of our results go beyond insulin and diabetes. 

Phrase: "Although"

Phrase: "speculative,"

Phrase: "the possible implications of our results"

Phrase: "go beyond insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1822658:GO [Gene or Genome]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.148: Insulin-degrading enzyme has been shown to degrade a number of hormones such as atrial natriuretic peptide, transforming growth factor-, and amylin (38, 39, 40). 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "a number of hormones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "such as atrial natriuretic peptide,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "transforming growth factor-,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(38,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.149: It has been implicated in the degradation of amyloid  (41) as well as the -amyloid precursor protein intracellular domain (42). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the degradation of amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0243125:degradation [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0699900:Degradation [Organism Function]

Phrase: "(41"

Phrase: ")"

Phrase: "as well as"

Phrase: "the -amyloid precursor protein intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.150: Insulin-degrading enzyme has also been shown to bind to FAK-related nonkinase (43). 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to FAK-related nonkinase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0676896:FAK-related nonkinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.151: Thus, insulin-degrading enzyme has a number of potential ligands/substrates with which it interacts. 

Phrase: "Thus,"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "a number of potential ligands/substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "with which"

Phrase: "it"

Phrase: "interacts."
Processing 00000000.tx.152: The physiological relevance of these interactions and whether they are altered by FFAs remain to be elucidated.  

Phrase: "The physiological relevance of these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "and"

Phrase: "whether"

Phrase: "they"

Phrase: "are"

Phrase: "altered by FFAs"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0015688:Free Fatty Acids [Lipid]
   828 E C2698488:Free Fatty Acid [Laboratory Procedure]
   806   C0015684:Fatty Acids [Lipid]
   760   C0001128:Acids [Chemical]
   760   C0332296:free [Functional Concept]
   760   C0392747:Altered [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.153: Footnotes  This work was supported by funds from the Department of Veterans Affairs Merit Review Program (F.G.H.) and the Bly Memorial Research Fund. 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by funds"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016820:Funds [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]

Phrase: "from the Department of Veterans Affairs Merit Review Program"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C1709697:Program [Conceptual Entity]
   795   C2728259:Program [Pharmacologic Substance]
   795   C3484370:Program [Functional Concept]
   710   C3496098:Department of Veterans Affairs [Health Care Related Organization]

Phrase: "(F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H.)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the Bly Memorial Research Fund."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]
Processing 00000000.tx.154: Abbreviations: CoA, Coenzyme A; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "CoA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "Coenzyme A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.155: FFA, free fatty acid; 

Phrase: "FFA,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "free fatty acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0015688:free fatty acid [Lipid]
  1000   C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.156: LLVY, succinyl-leu-leu-val-tyr-7-amido-4-methyl coumarin; 

Phrase: "LLVY,"

Phrase: "succinyl-leu-leu-val-tyr-7-amido-4-methyl coumarin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010206:Cumarin [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.157: LSTR, boc-leu-ser-thr-arg-7-amido-4-methyl coumarin; 

Phrase: "LSTR,"

Phrase: "boc-leu-ser-thr-arg-7-amido-4-methyl coumarin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010206:Cumarin [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.158: TCA, trichloroacetic acid. 

Phrase: "TCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "trichloroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.159: Received November 4, 2002. 

Phrase: "Received November 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2002."
Processing 00000000.tx.160: Accepted for publication February 20, 2003.  

Phrase: "Accepted for publication February 20,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.161: References Top Abstract Introduction Materials and Methods Results Discussion References  Stromblad G, Bjorntorp P 1986 Reduced hepatic insulin clearance in rats with dietary-induced obesity. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Stromblad G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bjorntorp P 1986 Reduced hepatic insulin clearance in rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0449297:Clearance [Qualitative Concept]
   742   C1382187:Clearance [Clinical Attribute]
   742   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "with dietary-induced obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0028754:Obesity [Disease or Syndrome]
   827   C1963185:Obesity [Finding]
Processing 00000000.tx.162: Metabolism 35:323327[Medline] Strang BD, Bertics SJ, Grummer RR, Armentano LE 1998 Relationship of triglyceride accumulation to insulin clearance and hormonal responsiveness in bovine hepatocytes. 

Phrase: "Metabolism 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "323327"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strang BD,"

Phrase: "Bertics SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Grummer RR,"

Phrase: "Armentano LE 1998 Relationship of triglyceride accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "to insulin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "hormonal responsiveness in bovine hepatocytes."
Processing 00000000.tx.163: J Dairy Sci 81:740747[Abstract/Free FullText] Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A 1987 Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. 

Phrase: "J Dairy Sci 81"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1547276:Dairy [Intellectual Product]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "740747"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jimenez J,"

Phrase: "Zuniga-Guajardo S,"

Phrase: "Zinman B,"

Phrase: "Angel"

Phrase: "A 1987 Effects of weight loss"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in massive obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Obesity [Disease or Syndrome]
   861   C1963185:Obesity [Finding]

Phrase: "on insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "C-peptide dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "sequential changes in insulin production,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "sensitivity."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.164: J Clin Endocrinol Metab 64:661668[Abstract] Svedberg J, Stromblad G, Wirth A, Smith U, Bjorntorp P 1991 Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. 

Phrase: "J Clin Endocrinol Metab 64"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "661668"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Svedberg J,"

Phrase: "Stromblad G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wirth A,"

Phrase: "Smith U,"

Phrase: "Bjorntorp P 1991 Fatty acids in the portal vein of the rat"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0015684:Fatty Acids [Lipid]
   736   C0001128:Acids [Chemical]
   703 E C0202406:Acid [Laboratory Procedure]

Phrase: "regulate"

Phrase: "hepatic insulin clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.165: J Clin Invest 88:20542058[Medline] Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, Giacca A 1999 Free fatty acids impair hepatic insulin extraction in vivo. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "88"

Phrase: ":"

Phrase: "20542058"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wiesenthal SR,"

Phrase: "Sandhu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "McCall RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Tchipashvili V,"

Phrase: "Yoshii H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Polonsky K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shi ZQ,"

Phrase: "Lewis GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Mari A,"

Phrase: "Giacca"

Phrase: "A 1999 Free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "impair"

Phrase: "hepatic insulin extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.166: Diabetes 48:766774[Abstract] Hennes MM, Shrago E, Kissebah AH 1990 Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "766774"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hennes MM,"

Phrase: "Shrago E,"

Phrase: "Kissebah AH 1990 Receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0052441:AH Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "postreceptor effects of free fatty acids (FFA)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on hepatocyte insulin dynamics."
Processing 00000000.tx.167: Int J Obes 14:831841[Medline] Svedberg J, Bjorntorp P, Smith U, Lonnroth P 1990 Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. 

Phrase: "Int J Obes 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063789:INT [Organic Chemical]
   812   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "831841"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Svedberg J,"

Phrase: "Bjorntorp P,"

Phrase: "Smith U,"

Phrase: "Lonnroth P 1990 Free-fatty acid inhibition of insulin binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C2259198:inhibition of binding [Molecular Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "action in isolated rat hepatocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]
Processing 00000000.tx.168: Diabetes 39:570574[Abstract] Svedberg J, Bjorntorp P, Smith U, Lonnroth P 1992 Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats. 

Phrase: "Diabetes 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "570574"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Svedberg J,"

Phrase: "Bjorntorp P,"

Phrase: "Smith U,"

Phrase: "Lonnroth P 1992 Effect of free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin receptor binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1149501:insulin receptor binding [Molecular Function]
   913   C1623517:insulin binding [Molecular Function]
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "tyrosine kinase activity in hepatocytes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1150423:kinase activity [Molecular Function]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "isolated from lean"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "obese rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.169: Diabetes 41:294298[Abstract] Hamel FG, Posner BI, Bergeron JJ, Frank BH, Duckworth WC 1988 Isolation of insulin degradation products from endosomes derived from intact rat liver. 

Phrase: "Diabetes 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "294298"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJ,"

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Duckworth WC 1988 Isolation of insulin degradation products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]

Phrase: "from endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "derived from intact rat liver."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0205266:Intact [Qualitative Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1441547:Derived [Qualitative Concept]
   760   C1554187:Intact [Idea or Concept]
   760   C2346688:LIVER [Food]
   760   C3245521:derived [Idea or Concept]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.170: J Biol Chem 263:67036708[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 1994 Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "67036708"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1994 Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020792:Identification [Mental Process]
   812   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "isolation of a cytosolic proteolytic complex containing insulin degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0204727:Isolation [Therapeutic or Preventive Procedure]
   739   C0205409:Isolation [Functional Concept]
   739   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "the multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.171: Biochem Biophys Res Commun 202:10471053[CrossRef][Medline] Duckworth WC, Bennett RG, Hamel FG 1994 A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. 

Phrase: "Biochem Biophys Res Commun 202"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "10471053"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439214:fg [Quantitative Concept]
   827   C2348814:FG [Quantitative Concept]

Phrase: "A direct inhibitory effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on a cytosolic proteolytic complex containing insulin-degrading enzyme"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   877   C0030940:Proteolytic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1947941:Proteolytic Enzyme [Enzyme]
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.172: J Biol Chem 269:2457524580[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2457524580"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "of the insulin-degrading enzyme-proteasome complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.173: Diabetes 46:197203[Abstract] Hamel FG, Bennett RG, Harmon KS, Duckworth WC 1997 Insulin inhibition of proteasome activity in intact cells. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "197203"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Harmon KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Duckworth WC 1997 Insulin inhibition of proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in intact cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.174: Biochem Biophys Res Commun 234:671674[CrossRef][Medline] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin acts intracellularly on proteasomes through insulin-degrading enzyme. 

Phrase: "Biochem Biophys Res Commun 234"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "671674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "intracellularly on proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "through insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.175: Biochem Biophys Res Commun 244:390394[CrossRef][Medline] Bennett RG, Hamel FG, Duckworth WC 2000 Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. 

Phrase: "Biochem Biophys Res Commun 244"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "390394"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 2000 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the ubiquitin-dependent degrading activity of the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1325411:ubiquitin activity [Molecular Function]
   762   C1622946:proteasome activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.176: Endocrinology 141:25082517[Abstract/Free FullText] Camberos MC, Perez AA, Udrisar DP, Wanderley MI, Cresto JC 2001 ATP inhibits insulin-degrading enzyme activity. 

Phrase: "Endocrinology 141"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "25082517"

Phrase: "[Abstract/Free FullText"

Phrase: "] Camberos MC,"

Phrase: "Perez AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Udrisar DP,"

Phrase: "Wanderley MI,"

Phrase: "Cresto JC 2001 ATP"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin-degrading enzyme activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C1145751:insulin activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.177: Exp Biol Med (Maywood) 226:334341[Abstract/Free FullText] Duckworth WC, Heinemann M, Kitabchi AE 1972 Purification of insulin specific protease by affinity chromatography. 

Phrase: "Exp Biol Med (Maywood"

Phrase: ")"

Phrase: "226"

Phrase: ":"

Phrase: "334341"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Heinemann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kitabchi AE 1972 Purification of insulin specific protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "by affinity chromatography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0008551:Chromatography, Affinity [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   761 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.178: Proc Natl Acad Sci USA 69:36983702[Abstract] Hamel FG, Peavy DE, Ryan MP, Duckworth WC 1987 HPLC analysis of insulin degradation products from isolated hepatocytes. 

Phrase: "Proc Natl Acad Sci USA 69"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0450388:69 [Intellectual Product]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "36983702"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Ryan MP,"

Phrase: "Duckworth WC 1987 HPLC analysis of insulin degradation products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "from isolated hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.179: Effects of inhibitors suggest intracellular and extracellular pathways. 

Phrase: "Effects of inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "extracellular pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.180: Diabetes 36:702708[Abstract] Shii K, Baba S, Yokono K, Roth RA 1985 Covalent linkage of 125I insulin to a cytosolic insulin degrading enzyme. 

Phrase: "Diabetes 36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "702708"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Baba S,"

Phrase: "Yokono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA 1985 Covalent linkage of 125I insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0023745:linkage [Molecular Function]

Phrase: "to a cytosolic insulin degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.181: J Biol Chem 260:65036506[Abstract/Free FullText] Murakami K, Ide T, Nakazawa T, Okazaki T, Mochizuki T, Kadowaki T 2001 Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to and isoforms of peroxisome-proliferator-activated receptors by competing with agonists. 

Phrase: "J Biol Chem 260"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "65036506"

Phrase: "[Abstract/Free FullText"

Phrase: "] Murakami K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ide T,"

Phrase: "Nakazawa T,"

Phrase: "Okazaki T,"

Phrase: "Mochizuki T,"

Phrase: "Kadowaki T 2001 Fatty-acyl-CoA thioesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597572:thioester [Organic Chemical]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "recruitment of steroid receptor co-activator 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2949735:Recruitment [Activity]

Phrase: "to"

Phrase: "and"

Phrase: "isoforms of peroxisome-proliferator-activated receptors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   716   C0166418:Peroxisome Proliferator-Activated Receptors [Amino Acid, Peptide, or Protein,Receptor]
   704 E C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "by competing"

Phrase: "with agonists."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]
Processing 00000000.tx.182: Biochem J 353:231238[CrossRef][Medline] Thompson AL, Cooney GJ 2000 Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. 

Phrase: "Biochem J 353"

Phrase: ":"

Phrase: "231238"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thompson AL,"

Phrase: "Cooney GJ 2000 Acyl-CoA inhibition of hexokinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "human skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "is"

Phrase: "a potential mechanism of lipid-induced insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1522618:resistance mechanism [Clinical Attribute]
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.183: Diabetes 49:17611765[Abstract] Draznin B, Trowbridge M 1982 Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "17611765"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Draznin B,"

Phrase: "Trowbridge M 1982 Inhibition of intracellular proteolysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2249698:inhibition of proteolysis [Organism Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in isolated rat hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0227525:Hepatocytes [Cell]
   793 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.184: Possible role of internalized hormone. 

Phrase: "Possible role of internalized hormone."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.185: J Biol Chem 257:1198811993[Abstract/Free FullText] Peavy DE, Edmondson JW, Duckworth WC 1984 Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes. 

Phrase: "J Biol Chem 257"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1198811993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Edmondson JW,"

Phrase: "Duckworth WC 1984 Selective effects of inhibitors of hormone processing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in isolated hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.186: Endocrinology 114:753760[Abstract] Trowbridge M, Draznin B 1986 Insulin internalization and intracellular protein degradation: a quantitative correlation. 

Phrase: "Endocrinology 114"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "753760"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Trowbridge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Draznin B 1986 Insulin internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "intracellular protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0597297:Protein Degradation [Molecular Function]
   901   C0597304:Protein Degradation [Molecular Function]
   901   C1623036:Protein Degradation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "a quantitative correlation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.187: Horm Metab Res 18:156158[Medline] Hofmann CA, Lotan RM, Ku WW, Oeltmann TN 1983 Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin. 

Phrase: "Horm Metab Res 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "156158"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hofmann CA,"

Phrase: "Lotan RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Ku WW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1861696:WW [Disease or Syndrome]

Phrase: "Oeltmann TN 1983 Insulin-ricin B hybrid molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0567416:molecules [Substance]
   710 E C1521991:Molecular [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "an insulin-associated effect on cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.188: J Biol Chem 258:1177411779[Abstract/Free FullText] Miller DS 1988 Stimulation of RNA and protein synthesis by intracellular insulin. 

Phrase: "J Biol Chem 258"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1177411779"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miller DS 1988 Stimulation of RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "protein synthesis by intracellular insulin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0597295:Protein Synthesis [Molecular Function]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.189: Science 240:506509[Medline] Miller DS 1989 Stimulation of protein synthesis in stage IV Xenopus oocytes by microinjected insulin. 

Phrase: "Science 240"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "506509"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miller DS 1989 Stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in stage IV Xenopus oocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0597694:Xenopus oocyte [Cell]
   812   C0029045:Oocytes [Cell]

Phrase: "by microinjected insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.190: J Biol Chem 264:1043810446[Abstract/Free FullText] Miller DS, Sykes DB 1991 Stimulation of protein synthesis by internalized insulin. 

Phrase: "J Biol Chem 264"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1043810446"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miller DS,"

Phrase: "Sykes DB 1991 Stimulation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by internalized insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.191: J Cell Physiol 147:487494[Medline] Harada S, Smith RM, Smith JA, Jarett L 1993 Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway. 

Phrase: "J Cell Physiol 147"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "487494"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harada S,"

Phrase: "Smith RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Smith JA,"

Phrase: "Jarett L 1993 Inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0877008:enzyme inhibition [Disease or Syndrome]
   767   C1524081:Enzyme Inhibition [Physiologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "translocation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C2987521:Translocation [Activity]

Phrase: "to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "in H35 rat hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0677626:hepatoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0023903:Hepatoma [Neoplastic Process]
   812   C2239176:Hepatoma [Neoplastic Process]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "evidence of a cytosolic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.192: Endocrinology 132:22932298[Abstract] Harada S, Smith RM, Jarett L 1994 1, 10-Phenanthroline increases nuclear accumulation of insulin in response to inhibiting insulin degradation but has a biphasic effect on insulins ability to increase mRNA levels. 

Phrase: "Endocrinology 132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "22932298"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Harada S,"

Phrase: "Smith RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Jarett L 1994 1,"

Phrase: "10-Phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "nuclear accumulation of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0544910:Nuclear accumulation [Cell or Molecular Dysfunction]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to inhibiting insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "has"

Phrase: "a biphasic effect on insulins ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "mRNA levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.193: DNA Cell Biol 13:487493[Medline] Shah N, Zhang S, Harada S, Smith RM, Jarett L 1995 Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin. 

Phrase: "DNA Cell Biol 13"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0007634:Cell [Cell]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "487493"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shah N,"

Phrase: "Zhang S,"

Phrase: "Harada S,"

Phrase: "Smith RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Jarett L 1995 Electron microscopic visualization of insulin translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0175631:Visualization [Mental Process]
   742   C2827662:Visualization [Occupation or Discipline]

Phrase: "into the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nuclei of intact H35 hepatoma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   798   C0007610:Nucleus of cell [Cell Component]
           Cell Nuclei
           Nucleus

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "covalently linked Nanogold-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.194: Endocrinology 136:28252835[Abstract] Harada S, Smith RM, Jarett L 1999 Mechanisms of nuclear translocation of insulin. 

Phrase: "Endocrinology 136"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "28252835"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Harada S,"

Phrase: "Smith RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Jarett L 1999 Mechanisms of nuclear translocation of insulin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0441712:Mechanisms [Functional Concept]
   708 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.195: Cell Biochem Biophys 31:307319[CrossRef][Medline] Kupfer SR, Marschke KB, Wilson EM, French FS 1993 Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. 

Phrase: "Cell Biochem Biophys 31"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0007634:Cell [Cell]
   812   C0450355:31 [Intellectual Product]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "307319"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kupfer SR,"

Phrase: "Marschke KB,"

Phrase: "Wilson EM,"

Phrase: "French FS 1993 Receptor accessory factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "specific DNA binding of androgen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1148673:DNA Binding [Genetic Function]
   797   C1148623:androgen binding [Molecular Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "glucocorticoid receptors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.196: J Biol Chem 268:1751917527[Abstract/Free FullText] Kupfer SR, Wilson EM, French FS 1994 Androgen and glucocorticoid receptors interact with insulin degrading enzyme. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1751917527"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kupfer SR,"

Phrase: "Wilson EM,"

Phrase: "French FS 1994 Androgen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002844:Androgen [Hormone,Pharmacologic Substance]
   812   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucocorticoid receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interact with insulin degrading enzyme."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.197: J Biol Chem 269:2062220628[Abstract/Free FullText] Hamel FG, Bennett RG, Duckworth WC 1998 Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2062220628"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Duckworth WC 1998 Regulation of multicatalytic enzyme activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1327623:regulation of enzyme activity [Molecular Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.198: Endocrinology 139:40614066[Abstract/Free FullText] Duckworth WC, Bennett RG, Hamel FG 1997 The significance of intracellular insulin to insulin action. 

Phrase: "Endocrinology 139"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "40614066"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439214:fg [Quantitative Concept]
   827   C2348814:FG [Quantitative Concept]

Phrase: "The significance of intracellular insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "to insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.199: J Investig Med 45:2027[Medline] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin degradation: progress and potential. 

Phrase: "J Investig Med 45"

Phrase: ":"

Phrase: "2027"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.200: Endocr Rev 19:608624[Abstract/Free FullText] Muller D, Baumeister H, Buck F, Richter D 1991 Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. 

Phrase: "Endocr Rev 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "608624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Muller D,"

Phrase: "Baumeister H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Buck F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Richter D 1991 Atrial natriuretic peptide (ANP)"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   827   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   799   C0018792:Atrial [Body Part, Organ, or Organ Component]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0597421:natriuretic [Pharmacologic Substance]
   727 E C0524422:atria [Body Part, Organ, or Organ Component]
   727 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a high-affinity substrate for rat insulin-degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0178623:enzyme substrate [Chemical Viewed Functionally]
   742   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.201: Eur J Biochem 202:285292[Abstract] Hamel FG, Gehm BD, Rosner MR, Duckworth WC 1997 Identification of the cleavage sites of transforming growth factor by insulin-degrading enzymes. 

Phrase: "Eur J Biochem 202"

Phrase: ":"

Phrase: "285292"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Gehm BD,"

Phrase: "Rosner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Duckworth WC 1997 Identification of the cleavage sites of transforming growth factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0020792:Identification [Mental Process]
   736   C0205396:Identification [Qualitative Concept]

Phrase: "by insulin-degrading enzymes."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.202: Biochim Biophys Acta 1338:207214[Medline] Bennett RG, Duckworth WC, Hamel FG 2000 Degradation of amylin by insulin-degrading enzyme. 

Phrase: "Biochim Biophys Acta 1338"

Phrase: ":"

Phrase: "207214"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hamel FG 2000 Degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "by insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.203: J Biol Chem 275:3662136625[Abstract/Free FullText] Mukherjee A, Song E, Kihiko-Ehmann M, Goodman Jr JP, Pyrek JS, Estus S, Hersh LB 2000 Insulysin hydrolyzes amyloid  peptides to products that are neither neurotoxic nor deposit on amyloid plaques. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3662136625"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mukherjee A,"

Phrase: "Song E,"

Phrase: "Kihiko-Ehmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Goodman Jr JP,"

Phrase: "Pyrek JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Estus S,"

Phrase: "Hersh LB 2000 Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1415875:INSULYSIN [Gene or Genome]

Phrase: "hydrolyzes"

Phrase: "amyloid  peptides to products"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "neither neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "nor"

Phrase: "deposit on amyloid plaques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2936349:Deposit, Amyloid [Acquired Abnormality]
   770   C0333562:Deposit [Functional Concept]
Processing 00000000.tx.204: J Neurosci 20:87458749[Abstract/Free FullText] Edbauer D, Willem M, Lammich S, Steiner H, Haass C 2002 Insulin-degrading enzyme rapidly removes the -amyloid precursor protein intracellular domain (AICD). 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "87458749"

Phrase: "[Abstract/Free FullText"

Phrase: "] Edbauer D,"

Phrase: "Willem M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lammich S,"

Phrase: "Steiner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Haass C 2002 Insulin-degrading enzyme rapidly"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the -amyloid precursor protein intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: ")."
Processing 00000000.tx.205: J Biol Chem 277:1338913393[Abstract/Free FullText] Liu Y, Loijens JC, Martin KH, Karginov AV, Parsons JT 2002 The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1338913393"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu Y,"

Phrase: "Loijens JC,"

Phrase: "Martin KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Karginov AV,"

Phrase: "Parsons JT 2002"

Phrase: "The association of ASAP1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "an ADP ribosylation factor-GTPase activating protein,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0061928:GTPase-Activating Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1419277:GTPase-ACTIVATING PROTEIN [Gene or Genome]
   861   C2984553:GTPase-Activating Protein [Amino Acid, Peptide, or Protein]
   799   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:activating [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "with focal adhesion kinase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0059239:Focal Adhesion Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366894:FOCAL ADHESION KINASE [Gene or Genome]
  1000   C1565434:Focal Adhesion Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0887870:Focal Adhesion [Cell Component]
   901   C1512810:Focal Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0205234:Focal [Spatial Concept]
   755 E C1883677:Focality [Qualitative Concept]

Phrase: "contributes to the process of focal adhesion assembly."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C1325887:focal adhesion assembly [Cell Function]
   793   C0175633:Process of adhesion [Natural Phenomenon or Process]
           adhesion process
           Adhesion
   770   C0887870:Focal Adhesion [Cell Component]
   770   C1512810:Focal Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0205234:Focal [Spatial Concept]
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1522240:Process [Phenomenon or Process]
   744   C1706853:Assembly [Activity]
   744   C1879748:Assembly [Manufactured Object]
   744   C1880177:Contribute [Activity]
Processing 00000000.tx.206: Mol Biol Cell 13:21472156[Abstract/Free FullText]

Phrase: "Mol Biol Cell 13"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "21472156"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

